QuidelOrtho Corporation QDEL North America — Total revenues
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by QuidelOrtho Corporation in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: QuidelOrtho Corporation’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about QuidelOrtho Corporation's north america — total revenues.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is QuidelOrtho Corporation's north america — total revenues?
- QuidelOrtho Corporation (QDEL) reported north america — total revenues of $328.9M in Q1 2026.
- How has QuidelOrtho Corporation's north america — total revenues changed year-over-year?
- QuidelOrtho Corporation's north america — total revenues decreased by 19.1% year-over-year, from $406.7M to $328.9M.
- What is the long-term trend for QuidelOrtho Corporation's north america — total revenues?
- Over 4 years (2021 to 2025), QuidelOrtho Corporation's north america — total revenues has grown at a -0.2% compound annual growth rate (CAGR), from $1.5B to $1.49B.
- What does north america — total revenues mean?
- Represents the total gross income generated from the sale of diagnostic testing solutions and services within the North American market. This metric serves as a primary indicator of the company's market penetration and demand for its immunoassay and molecular testing products in the region.